Iovance Biotherapeutics Stock Price on December 17, 2024
| IOVA Stock | USD 7.38 0.16 2.22% |
Below is the normalized historical share price chart for Iovance Biotherapeutics extending back to October 15, 2010. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Iovance Biotherapeutics stands at 7.38, as last reported on the 22nd of December, with the highest price reaching 7.44 and the lowest price hitting 7.07 during the day.
If you're considering investing in Iovance Stock, it is important to understand the factors that can impact its price. Iovance Biotherapeutics holds Efficiency (Sharpe) Ratio of -0.0791, which attests that the entity had a -0.0791% return per unit of risk over the last 3 months. Iovance Biotherapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Iovance Biotherapeutics' Market Risk Adjusted Performance of (0.19), standard deviation of 4.15, and Risk Adjusted Performance of (0.07) to validate the risk estimate we provide.
At present, Iovance Biotherapeutics' Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock Shares Outstanding is expected to grow to about 246.9 M, whereas Common Stock Total Equity is forecasted to decline to 4,118. . As of December 22, 2024, Price To Sales Ratio is expected to decline to 1,286. In addition to that, Price Earnings Ratio is expected to decline to -4.52. Iovance Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 15th of October 2010 | 200 Day MA 10.2468 | 50 Day MA 9.4128 | Beta 0.594 |
Iovance |
Sharpe Ratio = -0.0791
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | IOVA |
Estimated Market Risk
| 4.14 actual daily | 36 64% of assets are more volatile |
Expected Return
| -0.33 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.08 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Iovance Biotherapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Iovance Biotherapeutics by adding Iovance Biotherapeutics to a well-diversified portfolio.
Price Book 2.9081 | Enterprise Value Ebitda (8.68) | Price Sales 24.756 | Shares Float 225.7 M | Wall Street Target Price 23.7692 |
Related Headline
Sarepta Therapeutics Headline on 17th of December 2024
Disposition of 11723 shares by Dallan Murray of Sarepta Ther... by MacroaxisInsider
Filed transaction by Sarepta Therapeutics Officer: Chief Customer Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Iovance Biotherapeutics Valuation on December 17, 2024
It is possible to determine the worth of Iovance Biotherapeutics on a given historical date. On December 17, 2024 Iovance was worth 7.73 at the beginning of the trading date compared to the closed value of 7.81. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Iovance Biotherapeutics stock. Still, in general, we apply an absolute valuation method to find Iovance Biotherapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Iovance Biotherapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Iovance Biotherapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 7.93 | 8.14 | 7.79 | 7.84 | 4,856,408 | |
12/17/2024 | 7.73 | 7.85 | 7.64 | 7.81 | 4,274,600 |
| 7.82 | 7.86 | 7.06 | 7.26 | 6,967,461 |
| Backtest Iovance Biotherapeutics | | | Iovance Biotherapeutics History | | | Iovance Biotherapeutics Valuation | Previous | Next |
Iovance Biotherapeutics Trading Date Momentum on December 17, 2024
| On December 18 2024 Iovance Biotherapeutics was traded for 7.26 at the closing time. The top price for the day was 7.86 and the lowest listed price was 7.06 . The trading volume for the day was 7 M. The trading history from December 18, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 7.04% . The trading delta at closing time against the current closing price is 8.19% . |
Iovance Biotherapeutics Fundamentals Correlations and Trends
By evaluating Iovance Biotherapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Iovance Biotherapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Iovance financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Iovance Biotherapeutics Stock history
Iovance Biotherapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Iovance is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Iovance Biotherapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Iovance Biotherapeutics stock prices may prove useful in developing a viable investing in Iovance Biotherapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 235.1 M | 246.9 M | |
| Net Loss | -356.3 M | -338.5 M |
Iovance Biotherapeutics Quarterly Net Working Capital |
|
Iovance Biotherapeutics Stock Technical Analysis
Iovance Biotherapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Iovance Biotherapeutics Period Price Range
Low | December 22, 2024
| High |
0.00 | 0.00 |
Iovance Biotherapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Iovance Biotherapeutics December 22, 2024 Market Strength
Market strength indicators help investors to evaluate how Iovance Biotherapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Iovance Biotherapeutics shares will generate the highest return on investment. By undertsting and applying Iovance Biotherapeutics stock market strength indicators, traders can identify Iovance Biotherapeutics entry and exit signals to maximize returns
Iovance Biotherapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Iovance Biotherapeutics' price direction in advance. Along with the technical and fundamental analysis of Iovance Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Iovance to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (0.48) | |||
| Total Risk Alpha | (0.55) | |||
| Treynor Ratio | (0.20) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Iovance Stock analysis
When running Iovance Biotherapeutics' price analysis, check to measure Iovance Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Iovance Biotherapeutics is operating at the current time. Most of Iovance Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Iovance Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Iovance Biotherapeutics' price. Additionally, you may evaluate how the addition of Iovance Biotherapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |